BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Drug Development

  Roche Abandons AKT Prostate Cancer Asset

  Roche is dropping its investigational AKT inhibitor ipatasertib, which was being assessed in a Phase III trial for castration-resistant prostate cancer, as well as several other candidates.

  February 2, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  FDA

  GSK Wins Approval for CKD Anemia Drug – with Conditions

  Wednesday, the FDA approved GSK’s daprodustat, now to be marketed as Jesduvroq, for the treatment of anemia due to chronic kidney disease in adult patients.

  February 2, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Patient Square Touts Record-Breaking $3.9B Inaugural Fund

  Patient Square Capital announced a record-breaking inaugural fund totaling $3.9 billion, proving even in an unstable economy, there’s still money to be made.

  February 2, 2023

   · 

  1 min read

   · 

  Kate Goodwin
• 

  Deals

  Karuna Plucks Goldfinch’s TRPC4/5 Assets for Anxiety, Mood Disorders

  Karuna Therapeutics acquired exclusive rights to Goldfinch Bio’s investigational TRPC4/5 channel candidates in a deal potentially worth $520 million.

  February 2, 2023

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Does CRISPR Have a Bias Problem?

  Recent scientific papers report errors in CRISPR gene editing linked to ancestry.

  February 2, 2023

   · 

  3 min read

   · 

  Gail Dutton
• 

  What to Do When You’re Given Tasks Above Your Experience Level

  To help you take on any task you’re given at work, BioSpace has provided a guide detailing what to do when you’re asked to do things above your experience level.

  February 2, 2023

   · 

  3 min read

   · 

  Franklin Carpenter
• Business

  Changes to Sobi’s management - February 02, 2023

  Anton Hoos, M.D., Ph.D., MBA will become Head of R&D and Medical Affairs and Chief Medical Officer and replace Anders Ullman, M.D., Ph.D. who will retire.

  February 2, 2023

   · 

  2 min read
• NeoDynamics Partners with Uniphar for US Distribution and Logistics

  NeoDynamics AB, a medical device company dedicated to advancing the diagnosis and care of cancer, announced it is partnering with global distribution and logistics giant Uniphar Group to ensure a successful US launch of NeoNavia®, its innovative pulse biopsy system.

  February 2, 2023

   · 

  2 min read
• BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility

  BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced construction completion of the Company’s first proprietary plasmid DNA manufacturing facility in Marburg, Germany.

  February 2, 2023

   · 

  8 min read
• Business

  Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results

  Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2022.

  February 2, 2023

   · 

  38 min read